Successful conclusion of the Third World Local Production Forum in Abu Dhabi
Abu Dhabi, United Arab Emirates – The third edition of World Local Production Forum concluded successfully in Abu Dhabi, United Arab Emirates, bringing together key decision-makers, industry leaders, international organizations, and technical experts to discuss the critical role of local production in advancing global health equity, health security, and sustainable development.
Held under the theme 'Advancing Local Production for Health Equity, Global Health Security and Sustainable Development', the three-day forum took place from April 7 to 9, 2025, and witnessed the participation of top government officials, pharmaceutical and healthcare industry leaders, and stakeholders from across the world.
In his closing remarks, His Excellency Dr. Thani bin Ahmed Al Zeyoudi, Minister of State for Foreign Trade and Chairman of the Emirates Drug Establishment (EDE), reaffirmed the UAE's commitment to advancing local pharmaceutical production. He emphasized that the UAE is rapidly solidifying its position as a leading global hub for pharmaceutical innovation and advanced healthcare technologies, noting that local production has become not only a healthcare priority but also a strategic development imperative.
'We are pleased to host this global forum in partnership with the World Health Organization, reflecting the UAE's deep commitment to expanding local manufacturing capabilities, supporting research and development systems, and maintaining the highest quality standards in the production and distribution of medical products,' His Excellency stated.
He added, 'Our National Strategy for Advanced Innovation enables us to integrate modern technologies such as artificial intelligence, big data, and smart manufacturing into all stages of healthcare production, while maintaining our commitment to environmental sustainability.'
Concluding his address, H.E stressed the importance of purposeful international cooperation, stating, 'Through this forum, we affirm that international collaboration is the path to constructive change. By linking investment to innovation and policy to impact, we can build a more inclusive and resilient healthcare system that serves communities everywhere.'
Her Excellency Dr. Fatima Al Kaabi, Director General of Emirates Drug Establishment (EDE), also delivered remarks during the forum, underscoring that the UAE is leading by example in building resilient and innovative pharmaceutical ecosystems capable of addressing evolving healthcare needs. 'Hosting the World Local Production Forum is a testament to the UAE's progress in the pharmaceutical manufacturing sector,' she said. 'We believe that investing in local capabilities is the cornerstone for ensuring health security and equitable access to essential treatments.'
Dr. Yukiko Nakatani, Assistant Director General for Access to Medicines and Health Products Division at the World Health Organization, highlighted the global relevance of the forum, stating, 'This forum comes at a critical time as health systems worldwide face growing challenges in ensuring timely and equitable access to essential health products. Strengthening local production is a foundational pillar for building more resilient healthcare systems, and the UAE provides a good example with holistic approach for other countries and regions.'
The forum featured a robust program of discussions across eight key thematic areas, including policies and regulatory frameworks for strengthening local production systems; innovative strategies for financing and investment; the promotion of research, innovation, and technology transfer across the pharmaceutical value chain; and pandemic preparedness through expanded manufacturing capacity, demand forecasting, and emergency financing.
Additional themes included the integration of artificial intelligence, digital transformation, and climate adaptation in transforming local manufacturing; the formation of strategic partnerships to support sustainable local production and epidemic preparedness; knowledge sharing through case studies of successful country-level initiatives; and the CEO Forum, which convened global executives to explore the pharmaceutical industry's role in shaping public health outcomes.
Her Excellency Dr. Al Kaabi also participated in a high-level panel titled 'Localizing Pharmaceutical Innovation', which brought together members of the PharmaGroup, representing 29 global pharmaceutical companies, and the Mycomed Association, which includes around 70 companies in the medical device and equipment sectors. During the session, Dr. Al Kaabi presented the vision of the Emirates Drug Establishment (EDE) to position the UAE as a global center for pharmaceutical innovation through the attraction of top talent, advanced technologies, and investment into the sector. She emphasized the role of pharmaceutical manufacturing in supporting economic diversification, knowledge economy transformation, and long-term healthcare system resilience.
Dr. Ashraf Malak and Dr. Dederick Koh, also speaking at the forum, highlighted the Pharmage Association's 20-year legacy in the UAE and its contributions to the availability of modern and innovative treatments. They commended the Emirates Drug Establishment (EDE) for its role in shaping a forward-thinking regulatory and industrial environment that is achieving tangible impact across the sector.
In another panel session, global health leaders explored the future of equitable access to medicines, regional manufacturing, innovation ecosystems, and pandemic preparedness.
Dr. Luis Pizarro, Executive Director, Drugs for Neglected Diseases initiative (DNDi) addressed the importance of health equity and the moral imperative to focus on neglected populations and diseases. He reflected on DNDi's work in building collaborative R&D platforms and promoting affordable access to life-saving treatments. 'The innovation ecosystem must serve those most in need. That means patients in the most vulnerable contexts must be central to our R&D agendas,' he emphasized. He mentioned strategies for strengthening local capacities to make local production a reality. First, he highlighted the importance of not just discussing technology transfer, but ensuring that countries also possess the necessary technological know-how to implement and sustain it. 'We cannot speak about technology transfer without ensuring the know-how is in place,' he said. Secondly, he stressed the need to invest in human capital—developing local expertise and skills to drive innovation and production. Finally, he called for the design of health solutions that are relevant to the needs of local populations, underscoring the importance of defining a target product profile that aligns with regional contexts and public health demands.
Dr. Asma Ibrahim Al Mannaei, Executive Director, Research and Innovation Center, Department of Health – Abu Dhabi presented Abu Dhabi's strategic vision for health innovation, emphasizing the Emirate's commitment to becoming a regional leader in research and development, clinical trials, and health technology advancement. 'Our vision is to position Abu Dhabi as a hub for health innovation in the region,' she affirmed. Dr. Al Mannaei highlighted a range of forward-looking initiatives, regulatory modernization, and the adoption of data-driven health solutions. She also emphasised the UAE's exemplary performance during the COVID-19 pandemic, noting that Abu Dhabi was ranked the number one most resilient city in pandemic crisis management. This success, she said, was achieved through strong collaboration between local and international entities, transforming the Emirate into a logistics and solutions hub for the region. Through these coordinated efforts, the UAE facilitated the delivery and management of over 260 million doses of vaccines to countries in need, showcasing its global solidarity and logistical excellence. She stated the importance of R&D and local production to ensure long-term sustainability and self-reliance in health systems, ultimately safeguarding the region.
Mr. Robert Matiru, Director of Programmes at UNITAID, emphasized the importance of moving beyond rhetoric to showcase tangible partnerships that have advanced local production capacity for equitable access to health tools. Highlighting the benefit of collaborations, Matiru explained how UNITAID structured a partnership that brought together critical resources. A catalytic $10 million investment—modest in scale but significant in impact—was mobilized under the Access to COVID-19 Tools (ACT) Accelerator. This funding enabled partnerships with diagnostic manufacturers in the UK (Mologic, now Global Access Diagnostics) and South Korea (Bionote), facilitating rapid technology transfer and know-how sharing. With this support, IPD developed the capacity to manufacture lateral flow COVID-19 rapid tests, meeting global regulatory and quality standards. Before this initiative, Africa imported approximately 90% of its rapid tests—amounting to over half a billion tests annually for diseases like HIV and malaria. This collaboration helped shift the paradigm: IPD expanded its production capacity to 75 million rapid tests per year, significantly enhancing self-reliance in diagnostics. 'This is a prime example of how thoughtful, well-structured partnerships—combining financing, technology transfer, and strategic market planning—can empower local manufacturers to play a key role in global health security,' Matiru concluded.
Mr. Rajinder Kumar Suri, CEO, Developing Countries Vaccine Manufacturers Network (DCVMN) shed light on the indispensable role of developing countries' vaccine manufacturers in pandemic response and preparedness. He discussed the lessons learned from COVID-19 and how vaccine equity was undermined by global supply chain gaps and overreliance on a few manufacturers. 'We cannot afford to repeat the mistakes of the past. Strengthening regional manufacturing hubs, especially in the Global South, is critical for timely access during future pandemics,' Mr. Suri stated. He advocated for technology transfer mechanisms, better regulatory alignment, and long-term funding strategies that empower regional players.
Mr. Guilherme Cintra, Head of Policy, Coalition for Epidemic Preparedness Innovations (CEPI) shared CEPI's vision for advancing equitable vaccine development and distribution in the face of future health emergencies. He highlighted CEPI's commitment to building robust, end-to-end R&D ecosystems that span from early-stage innovation to large-scale delivery. Underscoring the importance of collaboration, he stated, 'The concept of self-reliance is an illusion—we need to depend and help each other.' He emphasized the need for inclusive, cooperative approaches where regional stakeholders are not merely recipients but active contributors within global innovation pipelines, ensuring that solutions are shaped by and for the communities they serve.
As part of her engagements during the forum, Her Excellency Dr. Fatima Al Kaabi, conducted a visit to the Adcan Pharma manufacturing facility. During the meeting with the factory's management, both parties explored avenues for enhanced coordination and collaboration aimed at supporting the growth and sustainability of the local pharmaceutical manufacturing ecosystem. The discussions focused on reinforcing national capabilities and fostering innovation across the production value chain.
The third edition of the World Local Production Forum received comprehensive support from the Emirates Drug Establishment, in close cooperation with the World Health Organization and a broad network of international partners. It served as a dynamic platform for government leaders, policymakers, investors, and industry experts to address critical issues related to sustainable local production and global health security.
Key outcomes from this Forum included 4077 participants from 141 countries, 16 ministers and Engagement of over 229 international speakers representing government agencies, health institutions, regulatory bodies, and the private sector.
This reinforced the UAE's steadfast commitment to fostering global partnerships that accelerate local production capacities, ensuring equitable access to healthcare solutions worldwide. It also highlighted the country's growing prominence as a global hub for life sciences, pharmaceutical innovation, and advanced health technologies.
In a symbolic gesture marking the end of the forum, the hosting torch was officially handed over to the Republic of Indonesia, which will host the fourth edition of the World Local Production Forum in 2026. This transition reflects the spirit of international cooperation and continued momentum toward achieving inclusive, resilient, and sustainable health systems across the globe.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
11 hours ago
- Khaleej Times
Billy Joel misses documentary premiere after revealing rare brain condition diagnosis
Singer-songwriter and pianist Billy Joel missed the premiere of his documentary at the Tribeca Film Festival days after cancelling all of his tour dates and revealing his rare brain condition diagnosis. Directed by Susan Lacy and Jessica Levin, Billy Joel: And So It Goes, which premiered at the festival in New York, showcases the music icon's journey, never-before-seen archival footage, and candid interviews. Although he was not present at the Beacon Theatre, stars like Whoopi Goldberg, Tom Hanks, Robert De Niro, Mariska Hargitay and her husband, actor Peter Hermann, attended it, People magazine reported. Last month, Joel announced the cancellation of all of his upcoming concerts following a recent diagnosis of normal pressure hydrocephalus, a condition where excess cerebrospinal fluid builds up in the brain ventricles, the outlet said. According to a statement that was posted on his Instagram, his health condition has worsened from his recent performances, leading to problems with hearing, vision, and balance. As per his doctor's instructions, he is undergoing specific physical therapy and has been "advised to refrain from performing during this recovery period," according to People. Joel is "thankful for the excellent care he is receiving and is fully committed to prioritising his health," the statement said. "He is grateful for the support from fans during this time and looks forward to the day when he can once again take the stage," it continued. In a statement, Joel said he was "sincerely sorry to disappoint our audience." Joel's wife Alexis shared an Instagram update on his condition and recovery. "Thank you for the outpouring of love and support," she wrote alongside a photo of her with Billy and their daughters. "We are so grateful for the wonderful care and swift diagnosis we received." "Bill is beloved by so many, and to us, he is a father and husband who is at the centre of our world," added Alexis. "We are hopeful for his recovery," she wrote. "We look forward to seeing you all in the future," reported People.
Khaleej Times
2 days ago
- Khaleej Times
UAE: Some schools issue chickenpox advisories, doctors urge vaccinations
Doctors in the UAE are urging parents to ensure their children are vaccinated against chickenpox. This advisory follows health notices issued by a few schools after some reported cases of chickenpox. Institutions have also observed instances of scarlet fever, a bacterial infection, among students. Medics explained that chickenpox, a contagious viral infection, tends to see increased activity during the warmer months. Higher temperatures can contribute to the spread of the virus, especially in environments where children are in close contact for extended periods. Stay up to date with the latest news. Follow KT on WhatsApp Channels. Immunise with two doses Dr Hamza Rahhal, Pediatric Consultant at Saudi German Hospital Dubai, said the increase in chickenpox cases is noticeable in school environments. 'There has indeed been an increase in reported chickenpox (varicella) cases among children, particularly within school environments,' he said. Rahhal linked the trend to missed immunisations during the pandemic. 'During the pandemic, many routine childhood vaccinations were delayed or missed. Some parents may also have postponed non-essential clinic visits. This has left a cohort of children either unvaccinated or partially immunised, increasing susceptibility.' Echoing the concern, Dr Mohamed Shahid Padiyar, Specialist Pediatrician at Medcare Hospital Sharjah, noted a change in how the disease is presenting in some children. 'There has definitely been an increase in chickenpox cases recently, particularly among school-aged children. We're seeing more intense symptoms than usual in some cases — higher fevers, more widespread and inflamed rashes, and increased skin infections due to scratching,' he said. 'In rare cases, children develop complications like pneumonia or neurological symptoms, especially if they have a weakened immune system.' Dr Mamata Bothra, Specialist in Pediatrics and Neonatology at International Modern Hospital Dubai, added that high summer temperatures and poor immunity can worsen the situation. 'Severe chickenpox infections can be seen in individuals with weak immunity and with certain medical conditions. Rising summer temperature also can increase the chances of spread of virus,' she said. 'Prevention is possible and most important is to vaccinate the child at right age and complete two doses as recommended. Beyond vaccination, practice good hygiene and avoid exposure to infected individuals.' Cases in primary sections Meanwhile, one Dubai school, in a recent circular shared with parents, confirmed a few cases of chickenpox within its primary section. The school circular read, 'We are writing to inform you that a few cases of chickenpox have recently been reported in our Primary School. These include two students (in Year 2 and KG2) and one staff member. Chickenpox is a highly contagious viral infection, and we are taking all necessary precautions to protect the health and wellbeing of our school community.' The communication further assured parents of the steps taken to contain the spread. 'The affected individuals are isolating at home, and all impacted classrooms and shared areas were thoroughly disinfected. The situation is being closely monitored by the school's medical team. Parents have been informed that chickenpox typically has an incubation period of 10 to 21 days, with early symptoms including fever, fatigue, and red, itchy spots that often begin on the chest or abdomen.' Institutions clarified the protocol followed by their network of schools. Dr Mirrah Kandil, Group Medical Director at GEMS Education, 'Only when we have a confirmed case, do we notify the health authority and share an exposure hazard letter with parents. This informs parents about what to be aware of in terms of potential symptoms and to seek medical assistance early.' 'We have not seen a significant rise in cases in GEMS schools. We maintain a central infection control database, in which we log all cases across the GEMS group — and we have not seen any spikes,' she added. 'Chickenpox is a vaccine-preventable disease, and we urge parents and guardians to get timely vaccinations. Prevention is better than cure.' Other school leaders also reported scattered infections and outlined the response measures being followed. Dr Arogya Reddy, Principal of Ambassador School Sharjah, said while chickenpox cases haven't been reported at their school, scarlet fever has emerged among students. 'We've observed a few illnesses circulating in schools here. In addition to chickenpox, scarlet fever is also making rounds. While we haven't recorded any chickenpox cases in our school, we have seen instances of scarlet fever, which is infectious.' Reddy emphasised the school's detailed response protocol in such cases. 'Our protocol involves identifying the affected student, informing their family, and then notifying the relevant authorities, specifically the Preventive Department under the Ministry of Health and Prevention (MoHAP). Depending on the severity of the case, students are required to stay home for at least seven days. Upon their return, they must present a Fitness Certificate issued by their treating doctor.'
Khaleej Times
2 days ago
- Khaleej Times
India: Active Covid-19 cases cross 4000, 5 deaths reported in a day
The number of active Covid-19 cases in India is currently 4026, according to data shared by the Ministry of Health and Family Welfare on Tuesday. A total of five new Covid-19 deaths have also been reported in the country in the past 24 hours. Kerala continues to have the maximum number of cases, standing at 1416, followed by Maharashtra (494), Gujarat (397), and Delhi (393). Karnataka, Haryana, Tamil Nadu and Gujarat also recorded a sharp increase in active cases over the last few days. The spike is attributed to a highly transmissible new variant, several Indian media reports say. The highly contagious COVID-19 variant NB.1.8.1, along with LF.7, has been circulating rapidly in India and many other Asian countries. Elderly patients among the decased The five deaths recorded in the past day were one each in Kerala, Tamil Nadu and West Bengal and two in Maharashtra. Among the deceased were elderly patients, including an 80-year-old male from Kerala with severe pneumonia and a 73-year-old woman in Maharashtra with diabetes and hypertension. West Bengal reported its first COVID-related death of 2025 on Tuesday. A 43-year-old woman from Alipore in Kolkata, who had been on ventilator support at a private hospital for a week, succumbed to the virus. According to hospital sources, she was also suffering from Acute Coronary Syndrome, septic shock, and acute kidney injury. India has has recorded 32 Covid-related deaths since January 1. Severity of infections low Officials from the Indian Council of Medical Research and the health ministry have stated that the COVID-19 situation in India is being closely monitored while stressing that the severity of infections is low, with most of the patients being under home care and that there was no cause for worry. Dr Rajiv Behl, Director General of ICMR, on June 2 stated that genome sequencing of samples in West and South have shown that the variants leading to the current rise in cases are not severe and are sub variants of Omicron only.
